{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:16:14Z","timestamp":1778544974987,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG2019-23069"],"award-info":[{"award-number":["IG2019-23069"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["22HLT06"],"award-info":[{"award-number":["22HLT06"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.biopha.2026.119156","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:42:27Z","timestamp":1772030547000},"page":"119156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting ER stress in adrenocortical carcinoma: Celastrol as a novel therapeutic candidate"],"prefix":"10.1016","volume":"197","author":[{"given":"Aurora","family":"Schiavon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Evaristo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-0511","authenticated-orcid":false,"given":"Laura","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8640-2462","authenticated-orcid":false,"given":"Jessica","family":"Petiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ymera","family":"Pignochino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2883-6139","authenticated-orcid":false,"given":"Soraya","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Perotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Giachino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Terzolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Lo Iacono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2026.119156_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2026.119156_bib2","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","article-title":"Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993","volume":"49","author":"Kerkhofs","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2026.119156_bib3","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae012","article-title":"Incidence, treatment, and survival of adrenocortical carcinoma in Denmark 2003-2019","volume":"8","author":"Pedersen","year":"2024","journal-title":"J. Endocr. Soc."},{"issue":"1","key":"10.1016\/j.biopha.2026.119156_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eprac.2023.10.004","article-title":"Incidence and geographical distribution of adrenocortical carcinoma: retrospective analysis of a state cancer registry","volume":"30","author":"Balderrama-Brondani","year":"2024","journal-title":"Endocr. Pract."},{"issue":"2","key":"10.1016\/j.biopha.2026.119156_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Adrenocortical Carcinoma Registry, T. European Network for the Study of Adrenal, Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2026.119156_bib6","article-title":"Temporal trends in outcomes in patients with adrenocortical carcinoma: a multidisciplinary referral center experience (vol 107, pg 1239, 2022)","volume":"107","author":"Daher","year":"2022","journal-title":"J. Clin. Endocr. Metab."},{"issue":"10","key":"10.1016\/j.biopha.2026.119156_bib7","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1210\/clinem\/dgad199","article-title":"New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study","volume":"108","author":"Puglisi","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2026.119156_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S2213-8587(24)00378-4","article-title":"Adrenocortical carcinoma: a practical guide for clinicians","volume":"13","author":"Fassnacht","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119156_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvad002","article-title":"The management of postoperative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients","volume":"188","author":"Calabrese","year":"2023","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119156_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/000313481908500111","article-title":"Operative management of recurrent and metastatic adrenocortical carcinoma: a systematic review","volume":"85","author":"Lo","year":"2019","journal-title":"Am. Surg."},{"issue":"4","key":"10.1016\/j.biopha.2026.119156_bib11","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119156_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-025-02864-5","article-title":"Therapeutic frontiers in adrenocortical carcinoma: from standards to innovation","volume":"42","author":"Schaap","year":"2025","journal-title":"Med Oncol."},{"issue":"19","key":"10.1016\/j.biopha.2026.119156_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13195001","article-title":"Metabolic and endocrine toxicities of mitotane: a systematic review","volume":"13","author":"Bianchini","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.biopha.2026.119156_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092615","article-title":"Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer","volume":"12","author":"Basile","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119156_bib15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/07435800.2024.2402311","article-title":"Adverse events of adjuvant mitotane treatment for adrenocortical carcinoma","volume":"50","author":"Vodanovic","year":"2025","journal-title":"Endocr. Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119156_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.eprac.2024.11.007","article-title":"Comprehensive analysis of mitotane-related adverse events using the food and drug administration adverse event reporting system","volume":"31","author":"Wang","year":"2025","journal-title":"Endocr. Pr."},{"issue":"1","key":"10.1016\/j.biopha.2026.119156_bib17","doi-asserted-by":"crossref","first-page":"27960","DOI":"10.1038\/s41598-025-13241-7","article-title":"Therapeutic effects and mechanisms of Tripterygium wilfordii extracts in rheumatoid arthritis: a systematic review and meta-analysis of preclinical studies","volume":"15","author":"Chen","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119156_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105572","article-title":"Celastrol in metabolic diseases: Progress and application prospects","volume":"167","author":"Xu","year":"2021","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.119156_bib19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","article-title":"Treatment of obesity with celastrol","volume":"161","author":"Liu","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2026.119156_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftw059","article-title":"Control of autoimmune inflammation by celastrol, a natural triterpenoid","volume":"74","author":"Venkatesha","year":"2016","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.biopha.2026.119156_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114705","article-title":"A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes","volume":"162","author":"Song","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119156_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114882","article-title":"Celastrol as an emerging anticancer agent: current status, challenges and therapeutic strategies","volume":"163","author":"Wang","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2026.119156_bib23","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/ijc.29302","article-title":"ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK\/ATF2 pathway","volume":"136","author":"Lo Iacono","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119156_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2018.10.043","article-title":"Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells","volume":"842","author":"Li","year":"2019","journal-title":"Eur. J. Pharm."},{"issue":"54","key":"10.1016\/j.biopha.2026.119156_bib25","doi-asserted-by":"crossref","first-page":"93039","DOI":"10.18632\/oncotarget.21750","article-title":"Celastrol induces apoptosis in hepatocellular carcinoma cells via targeting ER-stress\/UPR","volume":"8","author":"Ren","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119156_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1285-x","article-title":"Celastrol mediates autophagy and apoptosis via the ROS\/JNK and Akt\/mTOR signaling pathways in glioma cells (vol 38, 184, 2019)","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Canc Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119156_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-024-03542-8","article-title":"Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer","volume":"24","author":"Huang","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.biopha.2026.119156_bib28","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1158\/0008-5472.CAN-05-4529","article-title":"Celastrol, a triterpene extracted from the Chinese \"Thunder of God Vine,\" is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119156_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.558741","article-title":"Celastrol: a review of useful strategies overcoming its limitation in anticancer application","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharm."},{"issue":"23","key":"10.1016\/j.biopha.2026.119156_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316701","article-title":"Albumin\/mitotane interaction affects drug activity in adrenocortical carcinoma cells: smoke and mirrors on mitotane effect with possible implications for patients' management","volume":"24","author":"Schiavon","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.biopha.2026.119156_bib31","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.biopha.2026.119156_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.biopha.2026.119156_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.biopha.2026.119156_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbrc.2010.03.050","article-title":"Celastrol: molecular targets of Thunder God Vine","volume":"394","author":"Salminen","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2026.119156_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000410","article-title":"HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction","volume":"8","author":"Gupta","year":"2010","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119156_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","article-title":"N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why","volume":"52","author":"Aldini","year":"2018","journal-title":"Free Radic. Res."},{"issue":"7","key":"10.1016\/j.biopha.2026.119156_bib37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.eprac.2025.03.012","article-title":"Navigating uncertainty in adjuvant mitotane therapy","volume":"31","author":"Terzolo","year":"2025","journal-title":"Endocr. Pr."},{"issue":"10","key":"10.1016\/j.biopha.2026.119156_bib38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2213-8587(23)00193-6","article-title":"Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study","volume":"11","author":"Terzolo","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"23","key":"10.1016\/j.biopha.2026.119156_bib39","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"F.-A.S. Group, Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.biopha.2026.119156_bib40","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.7150\/ijbs.99592","article-title":"Recent Trends in anti-tumor mechanisms and molecular targets of celastrol","volume":"20","author":"Zhu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"22","key":"10.1016\/j.biopha.2026.119156_bib41","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.7150\/thno.46728","article-title":"Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119156_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1498141","article-title":"Bridging the gap: the role of 3D cell cultures in mimicking tumor microenvironment for enhanced drug testing accuracy","volume":"13","author":"Zhou","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119156_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12192-016-0676-6","article-title":"The human HSP70 family of chaperones: where do we stand?","volume":"21","author":"Radons","year":"2016","journal-title":"Cell Stress Chaperon."},{"key":"10.1016\/j.biopha.2026.119156_bib44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.fob.2014.09.004","article-title":"Heat shock preconditioning protects against ER stress-induced apoptosis through the regulation of the BH3-only protein BIM","volume":"4","author":"Kennedy","year":"2014","journal-title":"Febs Open Bio"},{"issue":"11","key":"10.1016\/j.biopha.2026.119156_bib45","doi-asserted-by":"crossref","first-page":"10565","DOI":"10.1007\/s11033-022-07641-5","article-title":"HSPA6 and its role in cancers and other diseases","volume":"49","author":"Song","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2026.119156_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/JS9.0000000000002961","article-title":"Comprehensive analysis of an ATF\/CREB family-based signature with regard to prognosis and immune feature in adrenocortical carcinoma: a cohort study","author":"Wu","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.biopha.2026.119156_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117917","article-title":"Mitotane activates ATF4\/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells","volume":"184","author":"Schiavon","year":"2025","journal-title":"Biomed. Pharm."},{"issue":"20","key":"10.1016\/j.biopha.2026.119156_bib48","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1093\/nar\/gkx845","article-title":"Novel mechanisms of eIF2B action and regulation by eIF2alpha phosphorylation","volume":"45","author":"Bogorad","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119156_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1112253","article-title":"A stay of execution: ATF4 regulation and potential outcomes for the integrated stress response","volume":"16","author":"Neill","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119156_bib50","article-title":"Role of eIF2\u03b1 kinases in translational control and adaptation to cellular stress","volume":"10","author":"Wek","year":"2018","journal-title":"Csh Perspect. Biol."},{"key":"10.1016\/j.biopha.2026.119156_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00213","article-title":"A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress","volume":"8","author":"Chaudhari","year":"2014","journal-title":"Front. Cell Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119156_bib52","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","article-title":"Oxidative stress and cancer: an overview","volume":"12","author":"Sosa","year":"2013","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119156_bib53","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12967-022-03741-9","article-title":"Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer","volume":"20","author":"Zhao","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119156_bib54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119156_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6793957","article-title":"Prooxidative activity of celastrol induces apoptosis, DNA damage, and cell cycle arrest in drug-resistant human colon cancer cells","author":"Moreira","year":"2019","journal-title":"Oxid. Med. Cell Longev. 2019"},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119156_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2003.12.020","article-title":"Adrenocortical cell lines","volume":"228","author":"Rainey","year":"2004","journal-title":"Mol. Cell Endocrinol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:53:40Z","timestamp":1778543620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":56,"alternative-id":["S0753332226001897"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119156","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting ER stress in adrenocortical carcinoma: Celastrol as a novel therapeutic candidate","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119156"}}